XML 81 R63.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Financial Statements of Parent Company (Tables)
12 Months Ended
Dec. 31, 2021
Condensed Financial Statements of Parent Company  
Schedule of condensed balance sheet

December 31,

 

(Dollars in thousands)

2021

2020

 

ASSETS

    

    

    

    

Cash

$

81,051

$

131,522

Investment in subsidiaries

 

5,039,776

 

4,802,993

Other assets

 

10,556

 

108,086

Total assets

$

5,131,383

$

5,042,601

LIABILITIES AND SHAREHOLDERS’ EQUITY

Corporate and subordinated debentures

$

327,066

$

390,179

Other Liabilities

1,377

4,542

Shareholders’ equity

 

4,802,940

 

4,647,880

Total liabilities and shareholders’ equity

$

5,131,383

$

5,042,601

Schedule of condensed statements of income

Year Ended December 31,

 

(Dollars in thousands)

2021

2020

2019

 

Income:

    

    

    

    

    

    

Dividends from subsidiaries

$

200,083

$

90,404

$

214,852

Operating income

 

25

 

52

 

5,386

Total income

 

200,108

 

90,456

 

220,238

Operating expenses

 

40,727

 

45,574

 

15,409

Income before income tax benefit and equity in undistributed earnings of subsidiaries

 

159,381

 

44,882

 

204,829

Applicable income tax benefit

 

9,053

 

8,960

 

1,883

Equity in undistributed earnings of subsidiaries (excess distribution)

 

307,109

 

66,790

 

(20,229)

Net income available to common shareholders

$

475,543

$

120,632

$

186,483

Schedule of condensed statements of cash flows

Year Ended December 31,

 

(Dollars in thousands)

2021

2020

2019

 

Cash flows from operating activities:

    

    

    

    

    

    

Net income

$

475,543

$

120,632

$

186,483

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

 

1,382

 

1,528

 

666

Share-based compensation

 

25,721

 

23,316

 

8,839

Extinguishment of debt cost

11,706

Gain on sale of securities available for sale

 

 

 

(5,366)

Decrease (increase) in other assets

 

5,690

 

(11,710)

 

(159)

Decrease in other liabilities

 

(3,648)

 

(12,323)

 

(959)

Undistributed earnings of subsidiaries

 

(307,109)

 

(66,790)

 

20,229

Net cash provided by operating activities

 

209,285

 

54,653

 

209,733

Cash flows from investing activities:

Proceeds from sales and calls of other investment securities

5,366

Repayment of investments in and advances to subsidiaries

93,591

163,000

Net cash inflow from acquisitions

 

 

19,650

 

Net cash provided by investing activities

 

93,591

 

182,650

 

5,366

Cash flows from financing activities:

Repayment of other borrowings

 

(75,878)

 

 

Common stock issuance

 

2,384

 

1,537

 

1,394

Common stock repurchased

 

(147,421)

 

(32,431)

 

(159,431)

Dividends paid on common stock

 

(135,337)

 

(98,256)

 

(57,696)

Stock options exercised

 

2,905

 

1,681

 

1,230

Net cash used in financing activities

 

(353,347)

 

(127,469)

 

(214,503)

Net (decrease) increase in cash and cash equivalents

 

(50,471)

 

109,834

 

596

Cash and cash equivalents at beginning of period

 

131,522

 

21,688

 

21,092

Cash and cash equivalents at end of period

$

81,051

$

131,522

$

21,688